Skip to main content
Log in

Dermatofibrosarcoma Protuberans at the Site of a Central Venous Line

Case Report

  • Case Report
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a locally aggressive cutaneous tumor that usually does not metastasize. Clinically, it may present as a reddish macule to protuberant nodule affecting the trunk and proximal extremities of young and middle-aged adults. Histologically, it is characterized by a monomorphous storiform proliferation of spindle cells, involving the dermis and hypodermis, with a honeycomb pattern of infiltration of the subcutaneous fat. In case of difficulty in diagnosis, immunohistochemical markers (especially CD34) are highly sensitive for DFSP. It is important to remember that the rarity of DFSP, its resemblance to hypertrophied scars and keloids, and its appearance at trauma sites sometimes make the diagnosis of DFSP difficult and delayed.

In the literature, DSFP was not described in a child until 1957. Here we report an instance of DFSP at an unusual site in a 9-year-old child, which was the location of a previous central venous line insertion in the left supraclavicular area. A complete excision of the tumor with a wide surgical margin of 3cm of visibly uninvolved tissue was performed, followed by a deltopectoral flap and skin split graft. Postoperatively, the patient’s general condition was stable and he was discharged after 5 days to be followed up 3 months later in our clinic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Fletcher CD, Evans BJ, MacArtney JC, et al. Dermatofibrosarcoma protuberans: a clinicopathological and immunohistochemical study with a review of the literature. Histopathology. 1985; 9 (9): 921–38

    Article  PubMed  CAS  Google Scholar 

  2. Weiss SW. Histological typing of soft tissue tumours. 2nd ed. WHO international histological classification of tumours. Berlin: Springer, 1994

    Google Scholar 

  3. Koh CK, Ko CB, Bury HP, et al. Dermatofibrosarcoma protuberans. Int J Dermatol. 1995; 34: 256–60

    Article  PubMed  CAS  Google Scholar 

  4. Taylor RW, Helwig EB. Dermatofibrosarcoma protuberans: a study of 115 cases. Cancer. 1962; 15: 717–25

    Article  PubMed  CAS  Google Scholar 

  5. Gloster HM. Dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996; 36: 355–74

    Article  Google Scholar 

  6. Chaung TY, Su WPD, Muller SA. Incidence of cutaneous T-cell lymphoma and other rare skin cancers in a defined population. J Am Acad Dermatol. 1990; 23: 254–6

    Article  Google Scholar 

  7. Enzinger FM, Weiss SW. Soft tissue tumors. 3rd ed. St Louis (MO): Mosby, 1995: 325–37

    Google Scholar 

  8. Pack GT, Tabah EJ. Dermatofibrosarcoma protuberans: a report of thirty-nine cases. AMA Arch Surg. 1951; 62: 391–411

    Article  PubMed  CAS  Google Scholar 

  9. Hadju SI. Pathology of soft tissue tumors. 1st ed.Philadelphia (PA): Lea & Febiger, 1979: 82

    Google Scholar 

  10. Fletcher CD, Theaker JM, Flanagan A, et al. Pigmented dermatofibrosarcoma protuberans (Bednar tumour): melanocytic colonization or neuroectodermal differentiation? A clinicopathological and immunohistochemical study. Histopathology. 1988; 13: 631–43

    Article  PubMed  CAS  Google Scholar 

  11. Prieto VG, Reed JA, Shea CR. CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans. J Cutan Pathol. 1994; 21: 324–9

    Article  PubMed  CAS  Google Scholar 

  12. Mark RJ, Bailet JW, Tran LM, et al. Dermatofibrosarcoma protuberans of the head and neck: a report of 16 cases. Arch Otolaryngol Head Neck Surg. 1993; 119: 891–6

    Article  PubMed  CAS  Google Scholar 

  13. Gutierrez G, Ospina JE, de Baez NE, et al. Dermatofibrosarcoma protuberans. Int J Dermatol. 1984; 23: 396–401

    Article  PubMed  CAS  Google Scholar 

  14. Escalona-Zapata J, Alvarez Fernandez E, Llorca Escuin F. The fibroblastic nature of dermatofibrosarcoma protuberans: a tissue culture and ultrastructural study. Virchows Arch A Pathol Anat Histol. 1981; 391: 165–75

    Article  PubMed  CAS  Google Scholar 

  15. Hashimoto K, Brownstein MH Jakobiec FA. Dermatofibrosarcoma protuberans: a tumor with perineural and endoneural features. Arch Dermatol. 1974; 11: 874–5

    Article  Google Scholar 

  16. Diaz-Cascajo C. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant. J Cutan Pathol. 1997; 24: 197–8

    Article  PubMed  CAS  Google Scholar 

  17. Laurier R, Wolff HH, Jones RE. An immunohistochemical study of dermatofibrosarcoma protuberans supports its fibroblastic character and contradicts neuroectodermal or histiocytic components. Am J Dermatopathol. 1990; 12: 25–30

    Article  Google Scholar 

  18. Pedeutour F, Simon MP, Minoletti F. Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement. Cytogenet Cell Genet. 1996; 72: 171–4

    Article  PubMed  CAS  Google Scholar 

  19. Pedeutour F, Lacour JP, Perrin C. Another case of t(17;22)(q22;q13) in an infantile dermatofibrosarcoma protuberans. Cancer Genet Cytogenet. 1996; 89: 175–6

    Article  PubMed  CAS  Google Scholar 

  20. Craver RD, Correa H, Kao Y, et al. Dermatofibrosarcoma protuberans with 46,XY,t(X;7) abnormality in a child. Cancer Genet Cytogenet. 1995; 80: 75–7

    Article  PubMed  CAS  Google Scholar 

  21. Mandahl N, Heim S, Willen H, et al. Supernumerary ring chromosome as the sole cytogenetic abnormality in a dermatofibrosarcoma protuberans. Cancer Genet Cytogenet. 1990; 49: 273–5

    Article  PubMed  CAS  Google Scholar 

  22. Green JJ, Heymann RH. Dermatofibrosarcoma protuberans occurring in smallpox vaccination scar. J Am Acad Dermatol. 2003; 48: S54–5

    Article  PubMed  Google Scholar 

  23. Keshen TH, Cedema PS, Savell Jr VH, et al. Clinical and pathological features of pediatric dermatofibrosarcoma protuberans. Ann Plast Surg. 1995; 35: 633–7

    Article  PubMed  CAS  Google Scholar 

  24. McKee PH, Fletcher CDM. Dermatofibrosarcoma protuberans presenting in infancy and childhood. J Cutan Pathol. 1991; 18: 241–6

    Article  PubMed  CAS  Google Scholar 

  25. McPeak CJ, Cruz T, Nicastri AD. Dermatofibrosarcoma protuberans: an analysis of 86 cases: five with metastasis. Ann Surg. 1967; 166: 803–16

    Article  PubMed  CAS  Google Scholar 

  26. Burkhardt BR, Soule EH, Winkelmann RK, et al. Dermatofibrosarcoma protuberans: study of fifty-six cases. Am J Surg. 1966; 111: 638–44

    Article  PubMed  CAS  Google Scholar 

  27. Bouyssou-Gauthier ML, Labrousse F, Longis B, et al. Dermatofibrosarcoma protuberans in childhood. Pediatr Dermatol. 1997; 14: 463–5

    Article  PubMed  CAS  Google Scholar 

  28. Garg SK, Subbuswamy SG, Alabi JO, et al. Dermatofibrosarcoma protuberans in Northern Nigeria: a clinico-pathological review of 17 cases. Clin Oncol. 1978; 4: 113–22

    PubMed  CAS  Google Scholar 

  29. Altman DA, Nickoloff BJ, Fivenson DP. Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumors. J Cutan Pathol. 1993; 16: 154–8

    Article  Google Scholar 

  30. McGregor JK. Role of surgery in the management of dermatofibrosarcoma protuberans. Ann Surg. 1961; 154: 255–8

    Article  PubMed  CAS  Google Scholar 

  31. Teirrer-Lacombe MJ, Gilloub L, Maire G, et al. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data. Am J Surg Pathol. 2003; 27 (1): 27–39

    Article  Google Scholar 

  32. Checketts SR, Hamilton TK, Baughman RD. Congenital and childhood dermatofibrosarcoma protuberans: a case report and review of the literature. J Am Acad Dermatol. 2000; 42: 907–13

    Article  PubMed  CAS  Google Scholar 

  33. Schmoeckel C, Albini A, Krieg T, et al. The fibroblastic nature of dermatofibrosarcoma protuberans: morphological investigations in vivo and in vitro. Arch Dermatol Res. 1985; 278: 138–47

    Article  PubMed  CAS  Google Scholar 

  34. Dupree WB, Langloss JM, Weiss SW. Pigmented dermatofibrosarcoma protuberans (Bednar tumor): a pathologic, ultrastructural and immunohistochemical study. Am J Surg Pathol. 1985; 9: 630–9

    Article  PubMed  CAS  Google Scholar 

  35. Abenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol. 1993; 15: 429–34

    Article  PubMed  CAS  Google Scholar 

  36. Weiss SW, Nickoloff BJ. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol. 1993; 17: 1039–45

    Article  PubMed  CAS  Google Scholar 

  37. Kutzner H. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin fixed, paraffin-embedded tissue. J Am Acad Dermatol. 1993; 28: 613–7

    Article  PubMed  CAS  Google Scholar 

  38. Shmookler BM, Enzinger FM. Giant cell fibroblastoma: a peculiar childhood tumor [abstract]. Lab Invest. 1982; 46: 76A

    Google Scholar 

  39. Khan H, Fekete E, From L. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa. Hum Pathol. 2001; 32: 50–6

    Article  Google Scholar 

  40. Kransdorf MJ, Meis Kindblom JM. Dermatofibrosarcoma protuberans: radiologic appearance. AJR Am J Roentgenol. 1994; 163: 391–4

    PubMed  CAS  Google Scholar 

  41. Sato N, Kimura K, Tomita Y. Recurrent dermatofibrosarcoma protuberans with myxoid and fibrosarcomatous changes paralleled by loss of CD34 expression. J Dermatol. 1995; 22: 665–72

    PubMed  CAS  Google Scholar 

  42. Bashara ME, Jules KT, Potter GK. Dermatofibrosarcoma protuberans: 4 years after local trauma. J Foot Surg. 1992; 31: 160–5

    PubMed  CAS  Google Scholar 

  43. Hoffmann E. Uber das Krollentreibende Fibrosarkom der Haut (Dermatofibrosarkoma protuberans). Dermal Ztschr. 1925; 43: 1–28

    Article  Google Scholar 

  44. Kahn TA, Liranzo MO, Vidimos AT, et al. Pathological case of the month: congenital dermatofibrosarcoma protuberans. Arch Pediatr Adolesc Med. 1996; 150: 549–50

    Article  PubMed  CAS  Google Scholar 

  45. Mbonde MP, Amir H, Kitinya JN. Dermatofibrosarcoma protuberans: a clinicopathological study in an African population. East Aft Med J. 1996; 73: 410–3

    CAS  Google Scholar 

  46. Rowsell AR, Poole MD, Godfrey AM. Dermatofibrosarcoma protuberans: the problems of surgical management. Br J Plast Surg. 1986; 39: 262–4

    Article  PubMed  CAS  Google Scholar 

  47. Smola MG, Soyer HP, Scharnagl E. Surgical treatment of dermatofibrosarcoma protuberans: a retrospective study of 20 cases with review of literature. Fur J Surg Oncol. 1991; 17: 447–53

    CAS  Google Scholar 

Download references

Acknowledgment

No sources of funding were used to assist in the preparation of this case report. The authors have no conflicts of interest that are directly relevant to the content of this case report.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Iqbal Bukhari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bukhari, I., Al Akloby, O. & Bedaiwi, Y. Dermatofibrosarcoma Protuberans at the Site of a Central Venous Line. Am J Clin Dermatol 6, 61–64 (2005). https://doi.org/10.2165/00128071-200506010-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200506010-00007

Keywords

Navigation